Every Form 4 that Tivic Health Systems, Inc. (TIVC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TIVC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TIVC filings page.
Valion Bio, Inc. granted its General Counsel & SVP of Legal, Melinda Lackey, an employee stock option to purchase 45,000 shares of common stock at an exercise price of $0.96 per share.
The option vests 25% on the first anniversary of the grant date, with the remaining 75% vesting in twelve equal quarterly installments over the following three years, and expires on May 1, 2036. After this grant, she holds options for 45,000 shares directly. This is a compensation-related award rather than an open-market purchase.
Tivic Health Systems, Inc. director Sheryle Bolton purchased 10,000 shares of Common Stock in an open-market transaction at $1.04 per share. Following this purchase, she holds 10,000 shares directly.
Tivic Health Systems director Christina Rizopoulos Valauri made an open-market purchase of company stock. She bought 19,000 shares of Tivic Health Systems, Inc. Common Stock on April 1, 2026 at a price of $0.9478 per share. After this transaction, she directly owns 19,000 shares.
Tivic Health Systems, Inc. Chief Financial Officer Lisa G. Wolf exercised restricted stock units that converted into 92 shares of Common Stock on March 18, 2026. The shares were acquired at a conversion price of $0.00 per share, reflecting compensation rather than an open-market purchase.
Following the transactions, Wolf directly holds 526 shares of Common Stock and 643 Restricted Stock Units. The filing notes these figures reflect a 1-for-17 reverse stock split completed on March 7, 2025, and that the RSUs vest over three years from December 18, 2023.
Tivic Health Systems, Inc. Chief Operating Officer Michael K. Handley reported the exercise or conversion of derivative securities into common stock. On February 18, 2026, he acquired 8,824 Restricted Stock Units and an associated 8,824 shares of Common Stock at a price of $0.00 per share. Following these transactions, he directly held 26,471 Restricted Stock Units and 8,824 shares of Common Stock. Each Restricted Stock Unit is convertible into one share of Common Stock, and the units vest over four years with an initial vesting after the first year, then in twelve equal quarterly installments.